Successful treatment of migrating partial seizures in Wolf-Hirschhorn syndrome with bromide

Ayako Itakura1, Yoshiaki Saito1, Yoko Nishimura1

  • 1Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan.

Brain & Development
|January 23, 2016
PubMed

Insights

This study reports the first case of Wolf-Hirschhorn syndrome presenting with migrating partial seizures. Treatment with phenobarbital and potassium bromide effectively controlled the epilepsy in this patient.

Area of Science:

  • Genetics
  • Neurology
  • Pediatrics

Background:

  • Wolf-Hirschhorn syndrome (WHS) is a rare genetic disorder associated with developmental delays and distinctive facial features.
  • Epilepsy is a known complication of WHS, but the specific seizure types and migratory patterns are not well-characterized.

Observation:

  • A 10-month-old girl with mild psychomotor developmental delay presented with hemiclonic convulsions.
  • Seizure activity evolved into bilateral tonic seizures and status epilepticus, characterized by migrating ictal EEG findings from temporal to frontal regions.
  • The patient exhibited characteristic facial features suggestive of WHS.

Findings:

  • Genetic analysis confirmed a 2.1-Mb terminal deletion on chromosome 4p, diagnosing WHS.
  • The patient's epilepsy featured migrating partial seizures, a novel presentation within WHS.
  • Phenobarbital and potassium bromide provided complete seizure control within 10 days.

Implications:

  • This case expands the phenotypic spectrum of WHS, highlighting migrating partial seizures as a potential manifestation.
  • Early diagnosis and appropriate anti-epileptic drug management are crucial for controlling seizures in WHS patients.
  • Further research is warranted to understand the neurobiological mechanisms underlying epilepsy in WHS.